Wunderlich’s syndrome associated with anticoa­ gulant treatment, heart failure, and post‐radiation vasculopathy (RCD code: I‐O)

Adam Pytlewski, Mateusz Siwek, Leszek Drabik, Miłosz Delikat, Dawid Śmietana, Ewa Sobieraj, Paweł Iwaszczuk, Adam Mazurek, Wojciech Płazak

Full Text:



Background: Wunderlich’s syndrome (WS) is an extremely rare condition, characterised by spontaneous haemorrhage into the subcapsular, perirenal, and retroperitoneal spaces. The most common cause is renal angiomyolipoma. Classic symptoms, such as acute flank pain, flank mass, and hypovolemic shock, known as Lenk’s triad, have limited sensitivity and specificity for detecting WS. High mortality may be related to the difficulties in diagnosis, poor disease recognition, and non‐specific symptoms and signs. Computed tomography (CT) is the method of choice for the diagnosis of WS. Depending on the severity of symptoms, a conservative or invasive approach is reasonable. Methods and results: We report the case of a 58‐year‐old male with multivalvular heart defect, atrial fibrillation, and exacerbation of chronic heart failure complicated with nontraumatic bleeding into the retroperitoneal space. CT revealed a massive
(14x11x26 cm) retroperitoneal and perirenal haematoma. The patient was successfully treated with transfusion of red blood cells, fresh frozen plasma, and intravenous fluids. Simultaneously, heart failure treatment was initiated. In view of the chronic and idiopathic character of the haematoma and successful conservative treatment, there was no indication for surgery. Discussion: Several factors might have
contributed to the bleeding. First, the patient was receiving anticoagulant treatment to reduce the risk of arterial thromboembolism in atrial fibrillation. Another possible cause is post‐radiation vasculopathy, an adverse effect of previous radiation therapy for malignant granuloma. The third factor which could have contributed to bleeding was the exacerbation of chronic heart failure and pulmonary hypertension. JRCD 2019; 4 (2): xx–xx


rare disease; valvular disease; atrial fibrillation; retroperitoneal bleeding; spontaneous haemorrhage; anticoagulation; echocardiography; computed tomography


Wunderlich C. Handbuch der Pathologie und Therapie. 2nd ed. St. 1856.

Zhang JQ, Fielding JR, Zou KH. Etiology of spontaneous perirenal hemorrhage: a meta‐analysis. J Urol 2002;167:1593–6.

Ahn T, Roberts MJ, Navaratnam A, et al. Changing etiology and management patterns for spontaneous renal hemorrhage: a systematic review of contemporary series. Int Urol Nephrol 2017;49:1897–905. doi:10.1007/s11 255‐017‐1694‐8

Vos N, Oyen R. Renal Angiomyolipoma: The Good, the Bad, and the Ugly. J Belgian Soc Radiol 2018;102:41. doi:10.5334/jbsr.1536

Daliakopoulos SI. Spontaneous retroperitoneal hematoma: a rare devastating clinical entity of a pleiada of less common origins. J Surg Tech Case Rep 2011;3:8–9. doi:10.4103/2006–8808.78 462

Flum AS, Hamoui N, Said MA, et al. Update on the Diagnosis and Management of Renal Angiomyolipoma. J Urol 2016;195:834–46. doi:10.1016/j.juro.2015.07.126

Sierra‐Díaz E, Belmonte‐Hernández MV, Villanueva‐Pérez MA, et al. Non‐traumatic spontaneous retroperitoneal bleeding: the effect of an early and accurate diagnosis. Cir Cir 2015;83:206–10. doi:10.1016/j.circir.2015.05.014

González‐Castro A, Ortiz‐Lasa M, García‐Reyero J, et al. Wünderlich syndrome due to a ruptured iliac vein secondary to deep venous thrombosis. Rev Española Patol 2018;51:197–202. doi:10.1016/j.patol.2017.07.001

Yamamato K, Yasunaga Y. Antiplatelet therapy and spontaneous perirenal hematoma. Int J Urol 2005;12:398–400. doi:10.1111/j.1442–2042.2005.01 059.x

Akuzawa N, Kurabayashi M. Multiple spontaneous hemorrhages after commencing warfarin therapy. SAGE open Med case reports

;6:2050313X18 778 380. doi:10.1177/2050313X18 778 380

Wang BH, Pureza V, Wang H. Editor’s choice: A tale of Wünderlich syndrome. J Surg Case Reports 2012;2012:rjs015. doi:10.1093/JSCR/RJS015

Mao Y, De Oliveira IS, Hedgire S, et al. Aetiology, imaging features, and evolution of spontaneous perirenal haemorrhage. Clin Radiol

;72:175.e19‐175.e26. doi:10.1016/j.crad.2016.08.010

Drabik L, Wołkow P, Undas A. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: Association with thrombin generation, endothelial injury and platelet activation. Thromb Res 2015;136:408–14. doi:10.1016/j.thromres.2015.05.028

Triscott J, Mercer S, Tian PGJ, et al. Retroperitoneal haematoma associated with enoxaparin use in an elderly woman with chronic kidney disease. BMJ Case Rep 2015;2015:bcr2 015 211 699. doi:10.1136/bcr‐2015‐211 699

Drabik L, Wołkow P, Undas A. Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation. Stroke 2017;48:2716–22. doi:10.1161/STROKEAHA.117.018 143

DiNicolantonio JJ, D’Ascenzo F, Tomek A, et al. Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial. Int J Cardiol 2013;168:1739–44. doi:10.1016/j.ijcard.2013.06.135

Health V, Management R. Vascular Health and Risk Management Dovepress Evaluation of bleeding in patients receiving direct oral anticoagulants. 2017;13–325. doi:10.2147/VHRM.S121 661

Weintraub NL, Jones WK, Manka D. Understanding radiation‐induced vascular disease. J Am Coll Cardiol 2010;55:1237–9. doi:10.1016/j.jacc.2009.11.053

Drabik L, Kopeć G, Podolec P. Rapid progressive idiopathic pulmonary arterial hypertension (RCD code: II‐1A.1). J Rare Cardiovasc Dis 2013;1:33–8. doi:http:// dx.doi.org/10.20 418%2Fjrcd.vol1no2.80

Rubiś P, Drabik L, Kopeć G, et al. The prognostic role of exercise echocardiography in heart failure. Kardiol Pol 2011;69:656–63.

Chan YC, Morales JP, Reidy JF, et al. Management of spontaneous and iatrogenic retroperitoneal haemorrhage: conservative management, endovascular intervention or open surgery? Int J Clin Pract 2007;62:1604–13. doi:10.1111/j.1742–1241.2007.01 494.x

Sunga KL, Bellolio MF, Gilmore RM, et al. Spontaneous Retroperitoneal Hematoma: Etiology, Characteristics, Management, and Outcome. J Emerg Med 2012;43:e157–61. doi:10.1016/j.jemermed.2011.06.006

DOI: http://dx.doi.org/10.20418%2Fjrcd.vol4no2.370


  • There are currently no refbacks.
Journal of Rare Cardiovascular Diseases (JRCD)
John Paul II Hospital in Kraków, 80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
e-mail: rarediseases@szpitaljp2.krakow.pl
Published by SoftQ sp. z o.o.
ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659
e-mail: softq@softq.pl